Skip to main content
SpringerLink
Log in

Neuroleptics Affect Neuropeptide S and NPSR mRNA Levels in the Rat Brain

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Neuropeptide S (NPS) has a multidirectional regulatory activity, especially when considered as a potent endogenous anxiolytic factor. Accumulating data suggests that neuroleptics affect peptidergic signaling in various brain structures. However, there is no information regarding the influence of treatment with antipsychotics on brain NPS expression. In the current study, we assessed the NPS and NPS receptor (NPSR) mRNA levels in the brains of rats shortly and chronically treated with chlorpromazine and olanzapine using quantitative real-time PCR. Both single-dose and long-term (4 months) olanzapine treatment led to the upregulation of NPS expression in the rat hypothalamus. It supports the hypothesis that NPS is involved in the dopamine-dependent anxiolytic actions of selected neuroleptics and possibly also in the pathophysiology of mental disorders. On the other hand, NPSR expression decreased after single-dose and chronic chlorpromazine administration in the hypothalamus, as well as after chronic olanzapine and chlorpromazine administration in the striatum and hippocampus. These results cast a new light on the pharmacology of antipsychotics and contribute to a better understanding of the mechanisms responsible for their action. Furthermore, our findings underline the complex nature of potential interactions between dopamine receptors and brain peptidergic pathways, which has potential clinical applications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  • Anedda F, Zucchelli M, Schepis D, Hellquist A, Corrado L, D’Alfonso S, Achour A, McInerney G, Bertorello A, Lordal M, Befrits R, Bjork J, Bresso F, Torkvist L, Halfvarson J, Kere J, D’Amato M (2011) Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1). PLoS One 6:e29523

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Angelucci F, Gruber SH, Caltagirone C, Mathe AA (2008) Differential effects of olanzapine, haloperidol and risperidone on calcitonin gene-related peptide in the rat brain. Neuropeptides 42:535–541

    Article  CAS  PubMed  Google Scholar 

  • Basta-Kaim A, Budziszewska B, Jaworska-Feil L, Tetich M, Kubera M, Leskiewicz M, Otczyk M, Lason W (2006) Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells—an involvement of protein kinases. Neuropsychopharmacology 31:853–865

    Article  CAS  PubMed  Google Scholar 

  • Beck B, Fernette B, Stricker-Krongrad A (2005) Peptide S is a novel potent inhibitor of voluntary and fast-induced food intake in rats. Biochem Biophys Res Commun 332:859–865

    Article  CAS  PubMed  Google Scholar 

  • Cannella N, Kallupi M, Ruggeri B, Ciccocioppo R, Ubaldi M (2013) The role of the neuropeptide S system in addiction: focus on its interaction with the CRF and hypocretin/orexin neurotransmission. Prog Neurobiol 100:48–59

    Article  CAS  PubMed  Google Scholar 

  • Cannella N, Economidou D, Kallupi M, Stopponi S, Heilig M, Massi M, Ciccocioppo R (2009) Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system. Neuropsychopharmacology 34:2125–2134

    Article  CAS  PubMed  Google Scholar 

  • Castro AA, Moretti M, Casagrande TS, Martinello C, Petronilho F, Steckert AV, Guerrini R, Calo G, Dal Pizzol F, Quevedo J, Gavioli EC (2009) Neuropeptide S produces hyperlocomotion and prevents oxidative stress damage in the mouse brain: a comparative study with amphetamine and diazepam. Pharmacol Biochem Behav 91:636–642

    Article  CAS  PubMed  Google Scholar 

  • Chauveau F, Lange MD, Jungling K, Lesting J, Seidenbecher T, Pape HC (2012) Prevention of stress-impaired fear extinction through neuropeptide S action in the lateral amygdala. Neuropsychopharmacology 37:1588–1599

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Clark SD, Duangdao DM, Schulz S, Zhang L, Liu X, Xu YL, Reinscheid RK (2011) Anatomical characterization of the neuropeptide S system in the mouse brain by in situ hybridization and immunohistochemistry. J Comp Neurol 519:1867–1893

    Article  CAS  PubMed  Google Scholar 

  • Cohrs S, Roher C, Jordan W, Meier A, Huether G, Wuttke W, Ruther E, Rodenbeck A (2006) The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects. Psychopharmacol (Berl) 185:11–18

    Article  CAS  Google Scholar 

  • Dannlowski U, Kugel H, Franke F, Stuhrmann A, Hohoff C, Zwanzger P, Lenzen T, Grotegerd D, Suslow T, Arolt V, Heindel W, Domschke K (2011) Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacol 36:1879–1885

    Article  CAS  Google Scholar 

  • Didonet JJ, Cavalcante JC, Souza Lde S, Costa MS, Andre E, Soares-Rachetti Vde P, Guerrini R, Calo G, Gavioli EC (2014) Neuropeptide S counteracts 6-OHDA-induced motor deficits in mice. Behav Brain Res 266:29–36

    Article  CAS  PubMed  Google Scholar 

  • Dine J, Ionescu IA, Stepan J, Yen YC, Holsboer F, Landgraf R, Eder M, Schmidt U (2013) Identification of a role for the ventral hippocampus in neuropeptide S-elicited anxiolysis. PLoS One 8:e60219

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Domschke K, Reif A, Weber H, Richter J, Hohoff C, Ohrmann P, Pedersen A, Bauer J, Suslow T, Kugel H, Heindel W, Baumann C, Klauke B, Jacob C, Maier W, Fritze J, Bandelow B, Krakowitzky P, Rothermundt M, Erhardt A, Binder EB, Holsboer F, Gerlach AL, Kircher T, Lang T, Alpers GW, Strohle A, Fehm L, Gloster AT, Wittchen HU, Arolt V, Pauli P, Hamm A, Deckert J (2011) Neuropeptide S receptor gene—converging evidence for a role in panic disorder. Mol Psychiatry 16:938–948

    Article  CAS  PubMed  Google Scholar 

  • Donner J, Haapakoski R, Ezer S, Melen E, Pirkola S, Gratacos M, Zucchelli M, Anedda F, Johansson LE, Soderhall C, Orsmark-Pietras C, Suvisaari J, Martin-Santos R, Torrens M, Silander K, Terwilliger JD, Wickman M, Pershagen G, Lonnqvist J, Peltonen L, Estivill X, D’Amato M, Kere J, Alenius H, Hovatta I (2010) Assessment of the neuropeptide S system in anxiety disorders. Biol Psychiatry 68:474–483

    Article  CAS  PubMed  Google Scholar 

  • Duangdao DM, Clark SD, Okamura N, Reinscheid RK (2009) Behavioral phenotyping of neuropeptide S receptor knockout mice. Behav Brain Res 205:1–9

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ebner K, Rjabokon A, Pape HC, Singewald N (2011) Increased in vivo release of neuropeptide S in the amygdala of freely moving rats after local depolarisation and emotional stress. Amino Acids 41:991–996

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Erdmann F, Kugler S, Blaesse P, Lange MD, Skryabin BV, Pape HC, Jungling K (2015) Neuronal expression of the human neuropeptide S receptor NPSR1 identifies NPS-induced calcium signaling pathways. PLoS One 10:e0117319

    Article  PubMed Central  PubMed  Google Scholar 

  • Fendt M, Imobersteg S, Burki H, McAllister KH, Sailer AW (2010) Intra-amygdala injections of neuropeptide S block fear-potentiated startle. Neurosci Lett 474:154–157

    Article  CAS  PubMed  Google Scholar 

  • Gruber SH, Nomikos GG, Mathe AA (2002) Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat. Neuropsychopharmacol 26:595–604

    Article  CAS  Google Scholar 

  • Guerrini R, Salvadori S, Rizzi A, Regoli D, Calo G (2010) Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor. Med Res Rev 30:751–777

    Article  CAS  PubMed  Google Scholar 

  • Huang XF, Deng C, Zavitsanou K (2006) Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats. Neuropeptides 40:213–219

    Article  CAS  PubMed  Google Scholar 

  • Jungling K, Seidenbecher T, Sosulina L, Lesting J, Sangha S, Clark SD, Okamura N, Duangdao DM, Xu YL, Reinscheid RK, Pape HC (2008) Neuropeptide S-mediated control of fear expression and extinction: role of intercalated GABAergic neurons in the amygdala. Neuron 59:298–310

    Article  PubMed Central  PubMed  Google Scholar 

  • Kiss A, Bundzikova J, Pirnik Z, Mikkelsen JD (2010) Different antipsychotics elicit different effects on magnocellular oxytocinergic and vasopressinergic neurons as revealed by Fos immunohistochemistry. J Neurosci Res 88:677–685

    CAS  PubMed  Google Scholar 

  • Kumsta R, Chen FS, Pape HC, Heinrichs M (2013) Neuropeptide S receptor gene is associated with Cortisol responses to social stress in humans. Biol Psychol 93:304–307

    Article  PubMed  Google Scholar 

  • Lage R, Dieguez C, Lopez M (2006) Caffeine treatment regulates neuropeptide S system expression in the rat brain. Neurosci Lett 410:47–51

    Article  CAS  PubMed  Google Scholar 

  • Lage R, Gonzalez CR, Dieguez C, Lopez M (2007) Nicotine treatment regulates neuropeptide system expression in the rat brain. Neurotoxicology 28:1129–1135

    Article  CAS  PubMed  Google Scholar 

  • Laruelle M (2014) Schizophrenia: from dopaminergic to glutamatergic interventions. Curr Opin Pharmacol 14:97–102

    Article  CAS  PubMed  Google Scholar 

  • Lennertz L, Quednow BB, Schuhmacher A, Petrovsky N, Frommann I, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Hofels S, Pukrop R, Klosterkotter J, Franke PE, Wolwer W, Gaebel W, Hafner H, Maier W, Wagner M, Mossner R (2012) The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response. Int J Neuropsychopharmacol 15:1205–1215

    Article  CAS  PubMed  Google Scholar 

  • Liu X, Zeng J, Zhou A, Theodorsson E, Fahrenkrug J, Reinscheid RK (2011) Molecular fingerprint of neuropeptide S-producing neurons in the mouse brain. J Comp Neurol 519:1847–1866

    Article  CAS  PubMed  Google Scholar 

  • Lukas M, Neumann ID (2012) Nasal application of neuropeptide S reduces anxiety and prolongs memory in rats: social versus non-social effects. Neuropharmacol 62:398–405

    Article  CAS  Google Scholar 

  • Meis S, Bergado-Acosta JR, Yanagawa Y, Obata K, Stork O, Munsch T (2008) Identification of a neuropeptide S responsive circuitry shaping amygdala activity via the endopiriform Nucleus. PLoS One 3:e2695

    Article  PubMed Central  PubMed  Google Scholar 

  • Oishi M, Kushikata T, Niwa H, Yakoshi C, Ogasawara C, Calo G, Guerrini R, Hirota K (2014) Endogenous neuropeptide S tone influences sleep-wake rhythm in rats. Neurosci Lett 581:94–97

    Article  CAS  PubMed  Google Scholar 

  • Okamura N, Garau C, Duangdao DM, Clark SD, Jungling K, Pape HC, Reinscheid RK (2011) Neuropeptide S enhances memory during the consolidation phase and interacts with noradrenergic systems in the brain. Neuropsychopharmacol 36:744–752

    Article  CAS  Google Scholar 

  • Paneda C, Huitron-Resendiz S, Frago LM, Chowen JA, Picetti R, de Lecea L, Roberts AJ (2009) Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotropin-releasing factor receptor 1 in mice. J Neurosci 29:4155–4161

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Pape HC, Jungling K, Seidenbecher T, Lesting J, Reinscheid RK (2010) Neuropeptide S: a transmitter system in the brain regulating fear and anxiety. Neuropharmacol 58:29–34

    Article  CAS  Google Scholar 

  • Park SW, Choi SM, Lee JG, Lee CH, Lee SJ, Kim NR, Kim YH (2011) Differential effects of ziprasidone and haloperidol on immobilization-stress-induced CRF mRNA expression in the hypothalamic paraventricular nucleus of rats. Neuropsychobiol 63:29–34

    Article  CAS  Google Scholar 

  • Pulga A, Ruzza C, Rizzi A, Guerrini R, Calo G (2012) Anxiolytic- and panicolytic-like effects of neuropeptide S in the mouse elevated T-maze. Eur J Neurosci 36:3531–3537

    Article  PubMed  Google Scholar 

  • Rogoz Z (2013) Combined treatment with atypical antipsychotics and antidepressants in treatment-resistant depression: preclinical and clinical efficacy. Pharmacol Rep 65:1535–1544

    Article  CAS  PubMed  Google Scholar 

  • Rojczyk E, Palasz A, Wiaderkiewicz R (2015) Effect of short and long-term treatment with antipsychotics on orexigenic/anorexigenic neuropeptides expression in the rat hypothalamus. Neuropeptides 51:31–42

    Article  CAS  PubMed  Google Scholar 

  • Shirayama Y, Ishima T, Oda Y, Okamura N, Iyo M, Hashimoto K (2015) Opposite roles for neuropeptide S in the nucleus accumbens and bed nucleus of the stria terminalis in learned helplessness rats. Behav Brain Res 291:67–71

    Article  CAS  PubMed  Google Scholar 

  • Si W, Aluisio L, Okamura N, Clark SD, Fraser I, Sutton SW, Bonaventure P, Reinscheid RK (2010) Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex. J Neurochem 115:475–482

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Tringali G, Lisi L, De Simone ML, Aubry JM, Preziosi P, Pozzoli G, Navarra P (2009) Effects of olanzapine and quetiapine on corticotropin-releasing hormone release in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 33:1017–1021

    Article  CAS  PubMed  Google Scholar 

  • Umathe SN, Wanjari MM, Manna SS, Jain NS (2009) A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol. Neuropeptides 43:251–257

    Article  CAS  PubMed  Google Scholar 

  • Xu YL, Gall CM, Jackson VR, Civelli O, Reinscheid RK (2007) Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500:84–102

    Article  CAS  PubMed  Google Scholar 

  • Xu YL, Reinscheid RK, Huitron-Resendiz S, Clark SD, Wang Z, Lin SH, Brucher FA, Zeng J, Ly NK, Henriksen SJ, de Lecea L, Civelli O (2004) Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron 43:487–497

    Article  CAS  PubMed  Google Scholar 

  • Zhang S, Jin X, You Z, Wang S, Lim G, Yang J, McCabe M, Li N, Marota J, Chen L, Mao J (2014) Persistent nociception induces anxiety-like behavior in rodents: role of endogenous neuropeptide S. Pain 155:1504–1515

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Histology, School of Medicine in Katowice, Medical University of Silesia, Medyków Street 18, Katowice, 40-752, Poland

    Artur Pałasz & Ewa Rojczyk

Authors
  1. Artur Pałasz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ewa Rojczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Artur Pałasz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pałasz, A., Rojczyk, E. Neuroleptics Affect Neuropeptide S and NPSR mRNA Levels in the Rat Brain. J Mol Neurosci 57, 352–357 (2015). https://doi.org/10.1007/s12031-015-0625-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-015-0625-3

Keywords

Search

Navigation